Co-Medic selected for CrossCare 2.0

We are pleased to announce that Co-Medic has been selected to participate in the CrossCare 2.0 project. During this project, Co-Medic will be tested in Flemish and Dutch care living labs. In Flanders, Co-Medic is working closely with Eerstelijnszone Brugge and POM West-Vlaanderen towards a pilot project in a dozen Bruges primary care practices. Through this collaboration, we expect to demonstrate the added value of Co-Medic for primary care teams. In the Netherlands, Co-Medic will work with CIC West-Brabant to conduct an in-depth market study to better map our potential on the Dutch market.

We look forward to the impact this project will have on healthcare in the border region and remain committed to our mission: delivering efficient data solutions for more efficient and effective primary care.

This project receives financial support from the European Union (Interreg) and the Dutch national government.

About CrossCare 2.0

Through CrossCare 2.0, Europe supports eight Flemish and Dutch care living labs for the development of new care innovations. It is the successor to the successful CrossCare project (2016-2021) where 30 care innovations were supported in Flemish and Dutch living labs.

On the one hand, companies or care organisations developing innovations can receive financial support from the CrossCare Innovation Fund, up to €100,000 per organisation. On the other hand, living labs on both sides of the border also support selected organisations by demonstrating, testing and evaluating innovations with end users. They are experts in co-creation and live testing with care users and professionals in their own living and working environment, and they provide that expertise free of charge within this project.

View the CrossCare 2.0 project page